Lista de obras - Thomas Klikovits - Dominio Público Uruguay

A rare indication for lung transplantation - pulmonary alveolar microlithiasis: institutional experience of five consecutive cases.

artículo científico publicado en 2016

Circulating activin A is a novel prognostic biomarker in malignant pleural mesothelioma - A multi-institutional study.

artículo científico publicado en 2016

Circulating complement component 4d (C4d) correlates with tumor volume, chemotherapeutic response and survival in patients with malignant pleural mesothelioma.

artículo científico publicado en 2017

Circulating fibrinogen is a prognostic and predictive biomarker in malignant pleural mesothelioma

scientific article published on 16 January 2014

Controversies in oncology: surgery for small cell lung cancer? It's time to rethink the case.

artículo científico publicado en 2018

Donor ventilation parameters as predictors for length of mechanical ventilation after lung transplantation: Results of a prospective multicenter study

artículo científico publicado en 2020

Epigenetic down-regulation of integrin α7 increases migratory potential and confers poor prognosis in malignant pleural mesothelioma.

artículo científico publicado en 2015

Extracorporeal membrane oxygenation support for complex tracheo-bronchial procedures†.

artículo científico publicado en 2014

Extrapleural pneumonectomy after induction chemotherapy: perioperative outcome in 251 mesothelioma patients from three high-volume institutions.

artículo científico publicado en 2014

FGF2 and EGF induce epithelial-mesenchymal transition in malignant pleural mesothelioma cells via a MAPKinase/MMP1 signal.

artículo científico publicado en 2018

Fibroblast growth factor receptor inhibition is active against mesothelioma and synergizes with radio- and chemotherapy.

artículo científico publicado en 2014

Fibulin-3 levels in malignant pleural mesothelioma are associated with prognosis but not diagnosis

artículo científico publicado en 2015

High circulating activin A level is associated with tumor progression and predicts poor prognosis in lung adenocarcinoma.

artículo científico publicado en 2016

KRAS-mutation incidence and prognostic value are metastatic site-specific in lung adenocarcinoma: poor prognosis in patients with KRAS mutation and bone metastasis.

artículo científico publicado en 2017

Ki67 index is an independent prognostic factor in epithelioid but not in non-epithelioid malignant pleural mesothelioma: a multicenter study

artículo científico publicado en 2015

Limited Tumor Tissue Drug Penetration Contributes to Primary Resistance against Angiogenesis Inhibitors

artículo científico publicado en 2017

Lobar lung transplantation--is it comparable with standard lung transplantation?

artículo científico publicado en 2014

Lung transplantation for COVID-19-associated acute respiratory distress syndrome in a PCR-positive patient

artículo científico publicado en 2020

Lung transplantation in patients with incidental early stage lung cancer-institutional experience of a high volume center.

artículo científico publicado en 2016

Management of malignant pleural mesothelioma - part 3 : Data from the Austrian Mesothelioma Interest Group (AMIG) database

artículo científico publicado en 2016

Management of malignant pleural mesothelioma-part 2: therapeutic approaches : Consensus of the Austrian Mesothelioma Interest Group (AMIG).

artículo científico publicado en 2016

Management of malignant pleural mesothelioma - part 1: epidemiology, diagnosis, and staging : Consensus of the Austrian Mesothelioma Interest Group (AMIG).

artículo científico publicado en 2016

Mediastinal staging by videomediastinoscopy in clinical N1 non-small cell lung cancer: a prospective multicentre study.

artículo científico publicado en 2017

New insights into the impact of primary lung adenocarcinoma location on metastatic sites and sequence: A multicenter cohort study

scientific article published on 05 November 2018

Nintedanib Is Active in Malignant Pleural Mesothelioma Cell Models and Inhibits Angiogenesis and Tumor Growth In Vivo

scientific article published on 03 May 2018

O9. Results of multimodality therapy including radical resections for Pancoast tumors: a retrospective study in high-volume center

artículo científico publicado en 2014

P31. Outcome after trimodality therapy with intracavitary hydrogen peroxide therapy in malignant pleural mesothelioma

artículo científico publicado en 2014

P34. Exploring cell plasticity in malignant pleural mesothelioma.

artículo científico publicado en 2014

P44. Activin A is novel circulating biomarker in lung cancer.

artículo científico publicado en 2014

P5. Multidisciplinary thoracic tumor board conferences—review of the literature and institutional experience.

artículo científico publicado en 2014

P6. Induction chemo- or chemoradiotherapy followed by resection for N2 positive NSCLC—a retrospective study.

artículo científico publicado en 2014

Pretreatment serum C-reactive protein levels predict benefit from multimodality treatment including radical surgery in malignant pleural mesothelioma: a retrospective multicenter analysis

artículo científico publicado en 2012

Solid predominant subtype in lung adenocarcinoma is related to poor prognosis after surgical resection: A systematic review and meta-analysis

scientific article published on 04 February 2019

Subtype-specific KRAS mutations in advanced lung adenocarcinoma: a retrospective study of patients treated with platinum-based chemotherapy.

artículo científico publicado en 2014

Surgery for T4 lung cancer invading the thoracic aorta: Do we push the limits?

artículo científico publicado en 2017

Telomerase reverse transcriptase promoter mutations identify a genomically defined and highly aggressive human pleural mesothelioma subgroup

artículo científico publicado en 2020

The FAK inhibitor BI 853520 inhibits spheroid formation and orthotopic tumor growth in malignant pleural mesothelioma

artículo científico publicado en 2018

Trabectedin Is Active against Malignant Pleural Mesothelioma Cell and Xenograft Models and Synergizes with Chemotherapy and Bcl-2 Inhibition In Vitro

artículo científico publicado en 2016

Trimodality therapy for Pancoast tumors: T4 is not a contraindication to radical surgery.

artículo científico publicado en 2017

Lista de obras de Thomas Klikovits

A rare indication for lung transplantation - pulmonary alveolar microlithiasis: institutional experience of five consecutive cases.

Circulating activin A is a novel prognostic biomarker in malignant pleural mesothelioma - A multi-institutional study.

Circulating complement component 4d (C4d) correlates with tumor volume, chemotherapeutic response and survival in patients with malignant pleural mesothelioma.

Circulating fibrinogen is a prognostic and predictive biomarker in malignant pleural mesothelioma

Controversies in oncology: surgery for small cell lung cancer? It's time to rethink the case.

Donor ventilation parameters as predictors for length of mechanical ventilation after lung transplantation: Results of a prospective multicenter study

Epigenetic down-regulation of integrin α7 increases migratory potential and confers poor prognosis in malignant pleural mesothelioma.

Extracorporeal membrane oxygenation support for complex tracheo-bronchial procedures†.

Extrapleural pneumonectomy after induction chemotherapy: perioperative outcome in 251 mesothelioma patients from three high-volume institutions.

FGF2 and EGF induce epithelial-mesenchymal transition in malignant pleural mesothelioma cells via a MAPKinase/MMP1 signal.

Fibroblast growth factor receptor inhibition is active against mesothelioma and synergizes with radio- and chemotherapy.

Fibulin-3 levels in malignant pleural mesothelioma are associated with prognosis but not diagnosis

High circulating activin A level is associated with tumor progression and predicts poor prognosis in lung adenocarcinoma.

KRAS-mutation incidence and prognostic value are metastatic site-specific in lung adenocarcinoma: poor prognosis in patients with KRAS mutation and bone metastasis.

Ki67 index is an independent prognostic factor in epithelioid but not in non-epithelioid malignant pleural mesothelioma: a multicenter study

Limited Tumor Tissue Drug Penetration Contributes to Primary Resistance against Angiogenesis Inhibitors

Lobar lung transplantation--is it comparable with standard lung transplantation?

Lung transplantation for COVID-19-associated acute respiratory distress syndrome in a PCR-positive patient

Lung transplantation in patients with incidental early stage lung cancer-institutional experience of a high volume center.

Management of malignant pleural mesothelioma - part 3 : Data from the Austrian Mesothelioma Interest Group (AMIG) database

Management of malignant pleural mesothelioma-part 2: therapeutic approaches : Consensus of the Austrian Mesothelioma Interest Group (AMIG).

Management of malignant pleural mesothelioma - part 1: epidemiology, diagnosis, and staging : Consensus of the Austrian Mesothelioma Interest Group (AMIG).

Mediastinal staging by videomediastinoscopy in clinical N1 non-small cell lung cancer: a prospective multicentre study.

New insights into the impact of primary lung adenocarcinoma location on metastatic sites and sequence: A multicenter cohort study

Nintedanib Is Active in Malignant Pleural Mesothelioma Cell Models and Inhibits Angiogenesis and Tumor Growth In Vivo

O9. Results of multimodality therapy including radical resections for Pancoast tumors: a retrospective study in high-volume center

P31. Outcome after trimodality therapy with intracavitary hydrogen peroxide therapy in malignant pleural mesothelioma

P34. Exploring cell plasticity in malignant pleural mesothelioma.

P44. Activin A is novel circulating biomarker in lung cancer.

P5. Multidisciplinary thoracic tumor board conferences—review of the literature and institutional experience.

P6. Induction chemo- or chemoradiotherapy followed by resection for N2 positive NSCLC—a retrospective study.

Pretreatment serum C-reactive protein levels predict benefit from multimodality treatment including radical surgery in malignant pleural mesothelioma: a retrospective multicenter analysis

Solid predominant subtype in lung adenocarcinoma is related to poor prognosis after surgical resection: A systematic review and meta-analysis

Subtype-specific KRAS mutations in advanced lung adenocarcinoma: a retrospective study of patients treated with platinum-based chemotherapy.

Surgery for T4 lung cancer invading the thoracic aorta: Do we push the limits?

Telomerase reverse transcriptase promoter mutations identify a genomically defined and highly aggressive human pleural mesothelioma subgroup

The FAK inhibitor BI 853520 inhibits spheroid formation and orthotopic tumor growth in malignant pleural mesothelioma

Trabectedin Is Active against Malignant Pleural Mesothelioma Cell and Xenograft Models and Synergizes with Chemotherapy and Bcl-2 Inhibition In Vitro

Trimodality therapy for Pancoast tumors: T4 is not a contraindication to radical surgery.